Our Blog

What is Lewy body dementia?

Lewy body dementia is the third most common form of dementia after Alzheimer’s disease and vascular dementia.   Lewy body dementia is caused when small deposits of […]

New Research for Parkinson’s Disease

At Re:Cognition Health, our team are passionate about early accurate diagnosis and intervention to optimise health and treatment plans for Parkinson’s disease. We are very enthused by […]

Dementia – What should I know?

Dementia has a growing public profile due to the renewed focus by the government and the increase in media coverage. With one person being diagnosed with dementia […]

What is Parkinson’s Disease?

Parkinson’s disease is a chronic neurological condition which is progressive, meaning the symptoms worsen over time. Approximately 145,000 in the UK have a diagnosis of Parkinson’s disease, […]

What is Alzheimer’s disease?

Alzheimer’s disease is the most common cause of dementia and accounts for 62% of all people experiencing symptoms of dementia. It’s important to understand that dementia is […]

Recognition Health at the Alzheimer’s Show

Thank you to everyone who came to see Re:Cognition Health at the Alzheimer’s Show on the weekend- what an insightful show it was! Our team thoroughly enjoyed […]

Autism Clinical Trials For Adults

Autism Clinical Trials For Adults At Re:Cognition Health, we are passionate about optimising the cognitive performance of individuals of all ages and are dedicated to pioneering new […]

Autism Spectrum Disorder

According to the National Autistic Society, autism affects more than 1 in 100 people in the UK. It’s a myth that people grow out of autism in […]

EY Entrepreneur Of The Year Awards

EY Entrepreneur Of The Year Awards Dr Emer MacSweeney announced as regional finalist Dr Emer MacSweeney, CEO, Medical Director and Consultant Neuroradiologist at Re:Cognition Health has been […]

New non-drug ADHD treatment reviewed by leading specialist

New non-drug ADHD treatment reviewed by leading specialist Dr Ferrin gives her insight into the first non-drug treatment which has recently received FDA approval for ADHD. Our […]